Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases Central Excise Central Excise + SC Central Excise - 2006 (3) TMI SC This

  • Login
  • Cases Cited
  • Referred In
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2006 (3) TMI 141 - SC - Central Excise


  1. 2023 (5) TMI 290 - SC
  2. 2023 (5) TMI 191 - SC
  3. 2016 (7) TMI 1057 - SC
  4. 2015 (8) TMI 1012 - SC
  5. 2013 (8) TMI 467 - SC
  6. 2012 (3) TMI 40 - SC
  7. 2009 (4) TMI 6 - SC
  8. 2008 (9) TMI 4 - SC
  9. 2008 (5) TMI 46 - SC
  10. 2006 (11) TMI 3 - SC
  11. 2024 (6) TMI 896 - HC
  12. 2023 (11) TMI 212 - HC
  13. 2023 (9) TMI 708 - HC
  14. 2023 (8) TMI 179 - HC
  15. 2023 (7) TMI 630 - HC
  16. 2023 (3) TMI 273 - HC
  17. 2022 (12) TMI 1378 - HC
  18. 2022 (6) TMI 1210 - HC
  19. 2020 (1) TMI 707 - HC
  20. 2019 (5) TMI 204 - HC
  21. 2019 (3) TMI 1817 - HC
  22. 2019 (6) TMI 1132 - HC
  23. 2019 (10) TMI 486 - HC
  24. 2018 (9) TMI 1424 - HC
  25. 2018 (7) TMI 668 - HC
  26. 2018 (6) TMI 1661 - HC
  27. 2018 (3) TMI 1683 - HC
  28. 2018 (2) TMI 1816 - HC
  29. 2017 (6) TMI 657 - HC
  30. 2017 (7) TMI 148 - HC
  31. 2017 (1) TMI 1465 - HC
  32. 2016 (1) TMI 1230 - HC
  33. 2015 (7) TMI 1421 - HC
  34. 2015 (11) TMI 1319 - HC
  35. 2014 (12) TMI 1408 - HC
  36. 2015 (2) TMI 751 - HC
  37. 2014 (10) TMI 449 - HC
  38. 2012 (12) TMI 908 - HC
  39. 2014 (5) TMI 368 - HC
  40. 2013 (4) TMI 22 - HC
  41. 2012 (2) TMI 465 - HC
  42. 2011 (12) TMI 471 - HC
  43. 2011 (1) TMI 1336 - HC
  44. 2010 (10) TMI 233 - HC
  45. 2010 (8) TMI 1090 - HC
  46. 2008 (9) TMI 845 - HC
  47. 2008 (7) TMI 870 - HC
  48. 2024 (11) TMI 271 - AT
  49. 2024 (10) TMI 334 - AT
  50. 2024 (8) TMI 1346 - AT
  51. 2024 (8) TMI 471 - AT
  52. 2024 (7) TMI 685 - AT
  53. 2024 (7) TMI 111 - AT
  54. 2024 (6) TMI 1110 - AT
  55. 2024 (5) TMI 943 - AT
  56. 2024 (2) TMI 1268 - AT
  57. 2024 (1) TMI 1170 - AT
  58. 2024 (1) TMI 147 - AT
  59. 2023 (12) TMI 17 - AT
  60. 2023 (11) TMI 485 - AT
  61. 2023 (10) TMI 801 - AT
  62. 2023 (9) TMI 826 - AT
  63. 2023 (8) TMI 615 - AT
  64. 2023 (8) TMI 1131 - AT
  65. 2023 (3) TMI 1131 - AT
  66. 2022 (12) TMI 1049 - AT
  67. 2022 (4) TMI 562 - AT
  68. 2021 (9) TMI 1267 - AT
  69. 2021 (6) TMI 1026 - AT
  70. 2021 (2) TMI 565 - AT
  71. 2019 (12) TMI 522 - AT
  72. 2019 (12) TMI 184 - AT
  73. 2019 (7) TMI 12 - AT
  74. 2019 (5) TMI 216 - AT
  75. 2018 (8) TMI 550 - AT
  76. 2018 (8) TMI 944 - AT
  77. 2018 (5) TMI 210 - AT
  78. 2018 (3) TMI 17 - AT
  79. 2018 (3) TMI 367 - AT
  80. 2018 (4) TMI 213 - AT
  81. 2018 (2) TMI 1723 - AT
  82. 2018 (2) TMI 1397 - AT
  83. 2017 (7) TMI 1178 - AT
  84. 2016 (12) TMI 533 - AT
  85. 2016 (11) TMI 7 - AT
  86. 2016 (3) TMI 511 - AT
  87. 2016 (4) TMI 600 - AT
  88. 2015 (10) TMI 1568 - AT
  89. 2015 (10) TMI 139 - AT
  90. 2013 (3) TMI 166 - AT
  91. 2012 (10) TMI 734 - AT
  92. 2011 (10) TMI 92 - AT
  93. 2011 (2) TMI 600 - AT
  94. 2008 (3) TMI 63 - AT
  95. 2007 (7) TMI 89 - AT
  96. 2024 (3) TMI 625 - AAAR
  97. 2023 (9) TMI 125 - AAR
  98. 2021 (12) TMI 267 - AAR
  99. 2019 (3) TMI 1407 - AAR
  100. 2018 (10) TMI 1871 - AAR
  101. 2018 (4) TMI 811 - AAR
  102. 2009 (9) TMI 938 - AAR
Issues Involved:
1. Classification of products as medicaments or cosmetics under the Central Excise Tariff Act, 1985.
2. Application of the twin test for determining product classification.
3. Evaluation of evidence and burden of proof regarding product classification.
4. Relevance of authoritative opinions and previous judgments in classification disputes.

Detailed Analysis:

1. Classification of Products:
The core issue was whether the products manufactured by the appellant should be classified as medicaments under Chapter 30 or as cosmetics under Chapter 33 of the Central Excise Tariff Act, 1985. The classification impacts the rate of excise duty, with medicaments attracting nil duty and cosmetics attracting a higher duty.

2. Application of the Twin Test:
The judgment emphasized the twin test for classification:
- Common Parlance Test: Whether the product is commonly understood as a medicament. If a product is used specifically for treating ailments and not for regular use, it is considered a medicament.
- Ayurvedic Ingredients Test: Whether the ingredients are mentioned in authoritative Ayurvedic texts.

The court noted that both tests are recognized by the Central Board of Excise and Customs and should be applied to determine the classification.

3. Evaluation of Evidence and Burden of Proof:
The appellant provided substantial evidence, including Ayurvedic texts, certificates from doctors, and opinions from Ayurvedic practitioners, to support the classification of their products as medicaments. The Collector (Appeals) relied on an opinion from the Directorate of Ayurveda, Maharashtra, which confirmed that the ingredients used in the products were described in Ayurvedic texts and were meant for treating skin diseases. The court highlighted that the burden of proving the correct classification lies with the revenue, which failed to provide any evidence to rebut the appellant's claims.

4. Relevance of Authoritative Opinions and Previous Judgments:
The court referenced several previous judgments where products with Ayurvedic ingredients were classified as medicaments. For instance:
- C.C.E. v. Sharma Chemical Works: The burden of proof lies with the revenue to show that a product is not a medicament.
- C.C.E. v. Pandit D. P. Sharma: Emphasized the common parlance test for classification.
- Naturalle Health Product (P) Ltd. v. C.C.E.: Followed the twin test for classification.
- Amrutanjan v. C.C.E.: Held that products with medicinal ingredients, even in small quantities, should be classified as medicaments.
- BPL Pharmaceuticals v. C.C.E.: Classified a medicated shampoo as a medicament based on its therapeutic use.
- Muller & Phipps (India) Ltd. v. C.C.E.: Classified Johnson Prickly Heat Powder as a medicament.
- Dabur (India) Ltd. v. C.C.E.: Classified products with Ayurvedic ingredients as medicaments.

Conclusion:
The court concluded that most of the appellant's products should be classified as medicaments under Chapter 30, except for Puma Herbal Massage Oil, Puma Herbal Massage Oil for Women, and Puma Scalp Tonic Powder, which were classified as cosmetics under Chapter 33. The appeals were allowed for the products classified as medicaments, and the matter was remanded to the Assistant Collector for quantification of duty for the products classified as cosmetics. The appeals in Civil Appeals No. 1414-1416/2004 were dismissed.

Products Classified as Medicaments:
- Puma Neem Facial Pack (Neemal)
- Puma Anti-Pimple Herbal Powder (Pimplex)
- Puma Herbal Facial Pack (Herbaucare)
- Puma Herbal remedy for Facial Blemishes
- Puma Hair Tonic Powder (Sukeshi)
- Puma Anti-Dandruff Oil (Dandika)
- Puma Shishu Rakshan Tel
- Puma Neem Tulsi

Products Classified as Cosmetics:
- Puma Herbal Massage Oil
- Puma Herbal Massage Oil for Women
- Puma Scalp Tonic Powder (Scalpton)

 

 

 

 

Quick Updates:Latest Updates